MedTrace Logo

Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors

NCT01663363 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2025-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.

Conditions

  • Myopia

Interventions

DEVICE

LASIK correction of myopic refractive errors

Surgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Principal Investigators

  • Kendra Hileman, PhD · Abbott Medical Optics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-03-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01663363 on ClinicalTrials.gov